<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Lung abscess in adults
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Lung abscess in adults
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Lung abscess in adults
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michael Klompas, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Stephen B Calderwood, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Paul Dieffenbach, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sheila Bond, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 11, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         A lung abscess is circumscribed, purulent infection contained within the lung parenchyma. Most lung abscesses arise as a complication of aspiration. As such, they are typically polymicrobial and indolent in onset. Less commonly, lung abscesses complicate acute monomicrobial infections with pyogenic bacteria (eg,
         <em>
          Staphylococcus aureus
         </em>
         ,
         <em>
          Klebsiella pneumoniae
         </em>
         , and
         <em>
          Pseudomonas aeruginosa
         </em>
         ). Lung abscesses can also result from secondary infection of pre-existing lung cavities, bronchial obstruction, septic embolization, or direct extension from local infections such as empyema.
        </p>
        <p>
         The clinical features, pathogenesis, evaluation, and treatment of lung abscesses will be reviewed here. Aspiration pneumonia, which may precede the development of a lung abscess, is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7024.html" rel="external">
          "Aspiration pneumonia in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          DEFINITIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lung abscess is defined as a circumscribed area of pus or necrosis in the pulmonary parenchyma caused by microbial infection. Lung abscesses can be classified as primary or secondary [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Primary lung abscesses result from direct infection of the pulmonary parenchyma in an otherwise healthy person. Most result from aspiration of oral or gastric contents. Primary lung abscesses can also arise within an area of pneumonia caused by necrotizing organisms (eg,
         <em>
          S. aureus
         </em>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Secondary lung abscesses occur when there is a predisposing condition such as bronchial obstruction (eg, foreign body, neoplasm), hematogenous spread (eg, right-sided endocarditis), thoracic surgery, or impaired host defenses.
        </p>
        <p>
        </p>
        <p>
         The terms "necrotizing pneumonia" or "lung gangrene" are used to describe pneumonia that is complicated by necrosis and numerous small abscesses [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most lung abscesses arise as a complication of aspiration that leads to one or more localized areas of pneumonia, followed by necrosis and cavitation. Other mechanisms include embolization (blood–borne), direct extension, endobronchial obstruction, or infection of lung cysts.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Aspiration
         </strong>
         – Lung abscess is classically caused by aspiration of oropharyngeal secretions especially in patients with recurrent aspiration who have dental, gingival, or periodontal infection or paranasal sinusitis. Anaerobes from the gingival crevice or sinuses reach the lower airways [
         <a href="#rid3">
          3
         </a>
         ]. Impaired swallowing and enteral feeding while supine are risk factors. Infection is initiated either because the secretions are not cleared due to suppressed consciousness, because the inoculum size is large, or due to impaired host defenses. Pneumonitis arises first and then progresses to tissue necrosis after 7 to 14 days. Risk factors for aspiration are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7024.html" rel="external">
          "Aspiration pneumonia in adults", section on 'Predisposing conditions'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hematogenous spread
         </strong>
         – Lung abscesses can occur as a consequence of septic embolization during bacteremia (eg, tricuspid valve endocarditis, intravascular catheters, intravenous (IV) drug use, or Lemierre syndrome [ie, jugular vein suppurative thrombophlebitis]). (See
         <a class="medical medical_review" href="/z/d/html/2149.html" rel="external">
          "Right-sided native valve infective endocarditis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2131.html" rel="external">
          "Catheter-related septic thrombophlebitis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/129255.html" rel="external">
          "Lemierre syndrome: Septic thrombophlebitis of the internal jugular vein", section on 'Complications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Direct extension
         </strong>
         – A lung abscess may develop by direct extension of an empyema, subphrenic, or mediastinal abscess or a tracheo- or broncho-esophageal fistula. (See
         <a class="medical medical_review" href="/z/d/html/115897.html" rel="external">
          "Bronchopleural fistula in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/115157.html" rel="external">
          "Tracheo- and broncho-esophageal fistulas in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bronchial obstruction
         </strong>
         – Endobronchial obstruction from a bronchogenic or mediastinal mass (eg, aneurysm, lymphadenopathy, tumor), bronchial stenosis, or from an inhaled foreign body may result in postobstructive pneumonia that progresses to abscess formation presumably due to impaired drainage of local pulmonary secretions [
         <a href="#rid4">
          4-6
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4384.html" rel="external">
          "Clinical presentation, diagnostic evaluation, and management of malignant central airway obstruction in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Superinfection or spread of airway infection
         </strong>
         – Lung abscess may develop as a superinfection of pulmonary infarcts, congenital malformations, or lung contusion. Flares of bronchiectasis can lead to parenchymal infection that evolves into a lung abscess in a minority of patients [
         <a href="#rid7">
          7,8
         </a>
         ]. The mechanism is likely multifactorial and includes poor drainage and impaired clearance of microbiologic flora from the lower airways.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          MICROBIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The microbiology of lung abscesses varies with the route of infection.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Aspiration
         </strong>
         — Lung abscesses that result from aspiration are typically polymicrobial, reflecting oral and gingival flora. The most commonly isolated pathogens are microaerophilic Streptococci and anaerobes. The most common anaerobes include
         <em>
          Peptostreptococcus
         </em>
         ,
         <em>
          Prevotella
         </em>
         ,
         <em>
          Bacteroides
         </em>
         (usually not
         <em>
          B. fragilis
         </em>
         ), and
         <em>
          Fusobacterium
         </em>
         [
         <a href="#rid9">
          9-18
         </a>
         ]. Common streptococci include
         <em>
          Streptococcus anginosus
         </em>
         and other members of the
         <em>
          Streptococcus milleri
         </em>
         group
         <em>
         </em>
         and oral streptococci such as
         <em>
          Streptococcus mitis
         </em>
         . Gram-negative organisms may be present in up to one-third of cases [
         <a href="#rid16">
          16,19,20
         </a>
         ]. These organisms may be a part of a polymicrobial infection or may be the sole pathogens. (See
         <a class="medical medical_review" href="/z/d/html/3178.html" rel="external">
          "Infections due to the
          <i>
           Streptococcus anginosus
          </i>
          (
          <i>
           Streptococcus milleri
          </i>
          ) group"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pneumonia caused by pyogenic bacteria
         </strong>
         — Aerobic bacteria that can cause monomicrobial lung abscess include
         <em>
          Staphylococcus aureus
         </em>
         (eg, in a patient with influenza) [
         <a href="#rid21">
          21,22
         </a>
         ],
         <em>
          Klebsiella pneumoniae
         </em>
         (eg, in a patient with structural lung disease) [
         <a href="#rid16">
          16,17,23,24
         </a>
         ], other Gram-negative bacilli (eg,
         <em>
          Pseudomonas
         </em>
         <em>
          aeruginosa
         </em>
         ) [
         <a href="#rid25">
          25
         </a>
         ],
         <em>
          Streptococcus pyogenes
         </em>
         [
         <a href="#rid26">
          26
         </a>
         ],
         <em>
          Burkholderia pseudomallei
         </em>
         [
         <a href="#rid27">
          27,28
         </a>
         ],
         <em>
          Haemophilus influenzae
         </em>
         type b,
         <em>
          Legionella
         </em>
         [
         <a href="#rid29">
          29,30
         </a>
         ],
         <em>
          Nocardia
         </em>
         , and
         <em>
          Actinomyces
         </em>
         . There have been occasional case reports of lung abscess caused by
         <em>
          Streptococcus pneumoniae
         </em>
         , although superinfection by anaerobic bacteria may be the cause in such cases [
         <a href="#rid31">
          31
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2135.html" rel="external">
          "Clinical manifestations of Staphylococcus aureus infection in adults", section on 'Pulmonary infection'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3152.html" rel="external">
          "Virulence determinants of community-acquired methicillin-resistant Staphylococcus aureus"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3122.html" rel="external">
          "Clinical features, diagnosis, and treatment of Klebsiella pneumoniae infection", section on 'Lung abscess'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5515.html" rel="external">
          "Nocardia infections: Epidemiology, clinical manifestations, and diagnosis", section on 'Lungs'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7035.html" rel="external">
          "Clinical manifestations and diagnosis of
          <i>
           Legionella
          </i>
          infection", section on 'Clinical features'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The bacteriology of lung abscess may be subject to geographic variability. For example, in a retrospective evaluation of 90 Taiwanese adults with lung abscess, Gram-negative bacilli (especially
         <em>
          K. pneumoniae
         </em>
         ) accounted for 36 percent of isolates (see
         <a class="medical medical_review" href="/z/d/html/3122.html" rel="external">
          "Clinical features, diagnosis, and treatment of Klebsiella pneumoniae infection"
         </a>
         ) [
         <a href="#rid16">
          16
         </a>
         ]. Other organisms included anaerobes (34 percent), Gram-positive cocci (26 percent), and Gram-positive bacilli (4 percent).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nonbacterial pathogens
         </strong>
         — Selected nonbacterial pathogens can generate or colonize cavitary lesions and radiographically resemble lung abscess. Culprit pathogens include many fungi (eg,
         <em>
          Aspergillus
         </em>
         spp,
         <em>
          Cryptococcus
         </em>
         spp,
         <em>
          Histoplasma capsulatum
         </em>
         ,
         <em>
          Blastomyces dermatitidis
         </em>
         ,
         <em>
          Coccidioides
         </em>
         spp, the agents of mucormycosis),
         <em>
          Mycobacterium tuberculosis
         </em>
         , nontuberculous mycobacteria (eg,
         <em>
          M. avium, M. kansasii, M. abscessus
         </em>
         ), and parasites (eg,
         <em>
          Entamoeba histolytica, Paragonimus westermani, Echinococcus
         </em>
         [hydatid cyst]). Pyogenic bacteria can also superinfect cavities caused by mycobacterial, fungal, and parasitic infections, leading to accumulation of liquid in an otherwise empty cavity. (See
         <a class="medical medical_review" href="/z/d/html/2454.html" rel="external">
          "Epidemiology and clinical manifestations of invasive aspergillosis", section on 'Pulmonary aspergillosis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2421.html" rel="external">
          "Cryptococcus neoformans infection outside the central nervous system"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2450.html" rel="external">
          "Pathogenesis and clinical features of pulmonary histoplasmosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2437.html" rel="external">
          "Clinical manifestations and diagnosis of blastomycosis", section on 'Pulmonary involvement'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2460.html" rel="external">
          "Primary pulmonary coccidioidal infection", section on 'Clinical manifestations'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2465.html" rel="external">
          "Mucormycosis (zygomycosis)", section on 'Pulmonary mucormycosis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7026.html" rel="external">
          "Pulmonary tuberculosis: Clinical manifestations and complications"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5342.html" rel="external">
          "Overview of nontuberculous mycobacterial infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5515.html" rel="external">
          "Nocardia infections: Epidemiology, clinical manifestations, and diagnosis", section on 'Lungs'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5728.html" rel="external">
          "Extraintestinal Entamoeba histolytica amebiasis", section on 'Pleuropulmonary infection'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5679.html" rel="external">
          "Paragonimiasis", section on 'Pulmonary paragonimiasis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Opportunistic infections
         </strong>
         — In the immunocompromised host, the most common causes of lung abscess are
         <em>
          Pseudomonas aeruginosa
         </em>
         and other aerobic Gram-negative bacilli,
         <em>
          Nocardia
         </em>
         spp, and fungi (
         <em>
          Aspergillus
         </em>
         and
         <em>
          Cryptococcus
         </em>
         spp). A number of other organisms can occasionally cause lung abscess in immunocompromised hosts, such as the agents of mucormycosis,
         <em>
          Rhodococcus equi
         </em>
         ,
         <em>
          Mycobacterium tuberculosis
         </em>
         , and nontuberculous mycobacteria  (
         <a class="graphic graphic_table graphicRef57589" href="/z/d/graphic/57589.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/3133.html" rel="external">
          "Pseudomonas aeruginosa pneumonia"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5515.html" rel="external">
          "Nocardia infections: Epidemiology, clinical manifestations, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2454.html" rel="external">
          "Epidemiology and clinical manifestations of invasive aspergillosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2421.html" rel="external">
          "Cryptococcus neoformans infection outside the central nervous system"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2465.html" rel="external">
          "Mucormycosis (zygomycosis)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5510.html" rel="external">
          "Clinical features, diagnosis, therapy, and prevention of
          <i>
           Rhodococcus equi
          </i>
          infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7026.html" rel="external">
          "Pulmonary tuberculosis: Clinical manifestations and complications"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5342.html" rel="external">
          "Overview of nontuberculous mycobacterial infections"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         An overview of pulmonary infections in immunocompromised patients is presented separately. (See
         <a class="medical medical_review" href="/z/d/html/1402.html" rel="external">
          "Epidemiology of pulmonary infections in immunocompromised patients"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          CLINICAL FEATURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical features of a lung abscess are typically nonspecific and mimic those of pneumonia, albeit with a more subacute presentation. It is typically the identification of one or more cavities filled with fluid or with an air-fluid interface on chest imaging that raises the suspicion for lung abscess.
        </p>
        <p class="headingAnchor" id="H2097899121">
         <span class="h2">
          Symptoms and signs
         </span>
         <span class="headingEndMark">
          —
         </span>
         The presenting signs and symptoms include fever and chills (80 percent), productive cough (often putrid, sour-tasting; 55 to 90 percent), dyspnea (10 percent), chest pain when the pleural space is involved (20 to 35 percent), and hemoptysis (10 percent) [
         <a href="#rid17">
          17,24,32-34
         </a>
         ]. Since abscesses of the lung are usually chronic, unlike pneumonia, most patients have symptoms that evolve over weeks to months. Systemic symptoms such as night sweats, weight loss, anorexia, and fatigue may also be present [
         <a href="#rid12">
          12,13,35
         </a>
         ].
        </p>
        <p>
         More rapid presentations with fulminant disease (eg, shock) may also occur with acute abscesses (eg,
         <em>
          Staphylococcus aureus
         </em>
         ,
         <em>
          Klebsiella pneumoniae
         </em>
         ), particularly in those who are immunocompromised, and those with septic emboli.
        </p>
        <p>
         Typical findings on physical examination are fever, gingival crevice disease (eg, gingivitis, dental caries), associated conditions that reduce consciousness or cause dysphagia (eg, facial or tongue weakness, bulbar speech, neurologic disease with deconditioning, alcohol intoxication). Chest auscultation may be normal or may demonstrate egophony or increased vocal fremitus, reflecting consolidation, particularly if the abscess is large and subpleural.
        </p>
        <p class="headingAnchor" id="H3776573729">
         <span class="h2">
          Chest radiograph
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lung abscesses are often visible on the chest radiograph, manifest as a fluid-filled space, typically with an air-fluid interface, within an area of consolidation, mass, or nodule  (
         <a class="graphic graphic_diagnosticimage graphicRef79327" href="/z/d/graphic/79327.html" rel="external">
          image 1
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef54525" href="/z/d/graphic/54525.html" rel="external">
          image 2
         </a>
         ), although more subtle forms of cavitation may only be appreciated on computed tomography of the chest (see
         <a class="local">
          'Chest computed tomography'
         </a>
         below). Most often, lung abscesses are unilateral [
         <a href="#rid32">
          32
         </a>
         ]. Because most cases are due to aspiration, abscesses are frequently located in a segment of the lung that is dependent in the recumbent position (eg, the superior segment of a lower lobe or a posterior segment of the upper lobes), or in the right middle lobe if aspiration occurred in the upright or prone position [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
         Lung abscesses caused by hematological dissemination may be distributed randomly or predominately in the lower lobes.
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          DIAGNOSTIC EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         A lung abscess should be suspected in a patient with clinical features of an indolent pulmonary infection (eg, fever, sweats, dyspnea, putrid or bloody sputum, weight loss, leukocytosis) and a cavitating or fluid-filled lung mass on imaging (see
         <a class="local">
          'Clinical features'
         </a>
         above). The focus of investigation is the identification of the probable pathogen and reasonable exclusion of other serious pathologies, particularly malignancy. After obtaining initial samples of blood and sputum, empiric antibiotic therapy should be initiated; antibiotic choices can be revised based on culture results. (See
         <a class="local">
          'Initial empiric antibiotics'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2774189914">
         <span class="h2">
          Clinical assessment
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The medical history should include questions about risk factors, such as dental pain or procedures, episodes of altered consciousness, neurologic disease, esophageal disease, alcohol or injection drug use, symptoms of extrapulmonary infection, history of immune deficiency or bronchiectasis, and prior similar episodes. Patients should also be asked about the timing of symptom onset, the presence of associated symptoms (eg, pharyngeal or neck pain, difficulty swallowing or coughing after swallowing, weight loss, night sweats), and smoking history since these may provide clues to the underlying etiology or organisms.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Physical examination should include a thorough examination of the oral cavity for halitosis, gingivitis, tonsillar enlargement, caries, loose, or tender teeth, and neck masses or tenderness. The patient should be asked to swallow a few sips of water to screen for dysphagia. (See
         <a class="medical medical_review" href="/z/d/html/1093.html" rel="external">
          "Complications of stroke: An overview", section on 'Dysphagia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Routine laboratory tests such as complete and differential blood count, chemistries, and liver and kidney function tests should be obtained. Laboratory findings are generally non-specific and include leukocytosis and anemia of chronic disease.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients who are immunocompromised, the potential causes of infection are broader and additional testing is often needed. (See
         <a class="medical medical_review" href="/z/d/html/1402.html" rel="external">
          "Epidemiology of pulmonary infections in immunocompromised patients"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1401.html" rel="external">
          "Approach to the immunocompromised patient with fever and pulmonary infiltrates"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with concomitant skin, nasal, kidney, or neurologic disease that suggests granulomatosis with polyangiitis should be tested for antineutrophil cytoplasmic antibodies (ANCA). (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/4330.html" rel="external">
          "Granulomatosis with polyangiitis and microscopic polyangiitis: Respiratory tract involvement"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1298728225">
         <span class="h2">
          Microbiologic testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         All patients should have two sets of blood cultures for both aerobic and anaerobic culture. Additional cultures from any suspected source are also appropriate (eg, intravascular catheter or wound). Sputum should be obtained for Gram stain and culture, ideally before antibiotics are started; however, antimicrobial therapy should not be withheld for those with signs of sepsis or septic shock. For patients who do not expectorate sputum, bronchoscopic sampling and/or percutaneous needle aspiration or (rarely) biopsy may be indicated. (See
         <a class="local">
          'Additional testing'
         </a>
         below.)
        </p>
        <p>
         A micro-organism present on Gram stain and abundant in culture is often a pathogen. However, care must be exercised in interpreting the results, particularly when antimicrobials have already been started, since sputum samples can yield contaminants from upper airway flora that do not need to be treated (eg,
         <em>
          Corynebacterium
         </em>
         spp) and may not reveal the presence of anaerobes that do need to be treated [
         <a href="#rid36">
          36
         </a>
         ]. Regardless of culture results, a putrid odor of expectorated sputum suggests an anaerobic infection and should be treated with an agent that includes activity against anaerobes. (See
         <a class="medical medical_review" href="/z/d/html/7018.html" rel="external">
          "Sputum cultures for the evaluation of bacterial pneumonia"
         </a>
         .)
        </p>
        <p>
         Despite obtaining respiratory cultures, up to 50 percent of patients do not have a positive culture and so antimicrobial therapy is empiric [
         <a href="#rid17">
          17,18
         </a>
         ].
        </p>
        <p>
         As bacterial infection can complicate mycobacterial cavities leading to an air-fluid interface, acid fast stains and mycobacterial cultures of sputum are prudent, especially if the cavity walls are thin or the patient has risk factors for
         <em>
          M. tuberculosis
         </em>
         . (See
         <a class="medical medical_review" href="/z/d/html/111683.html" rel="external">
          "Diagnosis of pulmonary tuberculosis in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3212751169">
         <span class="h2">
          Chest computed tomography
         </span>
         <span class="headingEndMark">
          —
         </span>
         When a lung abscess is suspected, chest computed tomography (CT) should be performed. CT provides more precise anatomic definition than chest radiography  (
         <a class="graphic graphic_diagnosticimage graphicRef79327" href="/z/d/graphic/79327.html" rel="external">
          image 1
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef54525" href="/z/d/graphic/54525.html" rel="external">
          image 2
         </a>
         ) and can identify other abscesses and thoracic lesions (eg, associated malignancy, lymphadenopathy, bullae) not clearly delineated on the chest radiograph [
         <a href="#rid1">
          1,35,37,38
         </a>
         ]. (See
         <a class="local">
          'Chest radiograph'
         </a>
         above.)
        </p>
        <p>
         CT findings of acute lung abscess include an area of cavitation surrounded by consolidation. The necrotic region tends to be irregular in shape. The wall of an acute abscess is often thick but can vary widely; the cavity wall typically becomes thin and uniform as the abscess heals. Air fluid levels within the abscess are common.
        </p>
        <p>
         A CT can also distinguish between a parenchymal lesion and a pleural collection (eg, parapneumonic effusion or empyema), which are managed very differently  (
         <a class="graphic graphic_diagnosticimage graphicRef82576" href="/z/d/graphic/82576.html" rel="external">
          image 3
         </a>
         ) and determine whether the abscess is due to an infected cyst or bulla, underlying congenital lesion (eg, infected sequestration), airway obstruction (eg, tumor, inhaled foreign body), or sub-diaphragmatic or pleural infection. Last, if surgery is indicated, CT facilitates decision-making regarding resection. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/6688.html" rel="external">
          "Imaging of pleural effusions in adults", section on 'Empyema'
         </a>
         and
         <a class="local">
          'Surgical intervention'
         </a>
         below.)
        </p>
        <p>
         Differentiating between peripheral lung abscesses and empyemas can occasionally be difficult [
         <a href="#rid39">
          39
         </a>
         ]. Abscesses tend to be more irregular in shape, spherical, and cavitated whereas empyemas tend to be better defined, elliptical, homogeneous, and have a smooth and uniform wall. Empyema may displace the blood vessels leading from the hilum to the periphery whereas abscesses typically do not.
        </p>
        <p class="headingAnchor" id="H1012425063">
         <span class="h2">
          Additional testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Additional testing may be warranted for patients who are unable to produce sputum, have an atypical presentation (eg, suspected cancer, noninfectious granulomatous disease), are immunocompromised, or do not respond to empiric antibiotics. As an example, bronchoscopy may be pursued more quickly in patients who are unable to raise sputum or have sputum that is not putrid and those who are at increased risk for opportunistic organisms due to immune deficiency or underlying lung disease  (
         <a class="graphic graphic_table graphicRef57589" href="/z/d/graphic/57589.html" rel="external">
          table 1
         </a>
         ), as early diagnosis and specific therapy of opportunistic infections are the cornerstone of successful management in such patients.
        </p>
        <p class="headingAnchor" id="H3945782967">
         <span class="h3">
          Bronchoscopy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Flexible bronchoscopy is not routinely needed but is reserved for patients without a microbiologic diagnosis after noninvasive testing (sputum and blood cultures) and those with atypical presentations, uncertain diagnosis, or immunocompromised state. (See
         <a class="local">
          'Additional testing'
         </a>
         above.)
        </p>
        <p>
         When performing bronchoscopy, the clinician should evaluate the airways in the areas of lung abscesses for endobronchial stenosis, foreign bodies, and lesions suspicious for malignancy that may be responsible for or mimic lung abscess. Samples of secretions observed in the affected region of the lung can be aspirated directly or by gentle washing of the area. However, caution is required as aggressive suctioning and sampling, including brushing, bronchoalveolar lavage, and transbronchial biopsy of the cavity, can cause sudden spillage of the abscess contents and acute respiratory distress syndrome [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p>
         Samples should be sent for cytology, routine Gram stain, aerobic culture and anaerobic culture, and special stains for
         <em>
          Nocardia,
         </em>
         <em>
          Actinomyces
         </em>
         , fungi,
         <em>
          Pneumocystis
         </em>
         , mycobacteria, and antigen testing for galactomannan. Visible airway lesions should be biopsied or brushed per usual practice. Further details on bronchoscopy are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/4398.html" rel="external">
          "Flexible bronchoscopy in adults: Overview"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4400.html" rel="external">
          "Flexible bronchoscopy in adults: Indications and contraindications"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/105799.html" rel="external">
          "Flexible bronchoscopy in adults: Preparation, procedural technique, and complications"
         </a>
         .)
        </p>
        <p>
         Obtaining samples using a protected specimen brush and subjecting them to quantitative cultures may reduce the chances of oral contamination and provide a better idea of the degree of growth; however, this approach is inconsistently available, costly, and may still be of low yield for anaerobic pathogens.
        </p>
        <p class="headingAnchor" id="H1909348624">
         <span class="h3">
          Other
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Transthoracic needle aspiration or biopsy
         </strong>
         – Transthoracic needle aspiration of the abscess or needle biopsy of the abscess wall under ultrasound, fluoroscopic, or CT guidance may be indicated for microbiologic sampling in rare patients who fail to improve with empiric antibiotic therapy and in whom sputum cultures and bronchoscopy are not revealing [
         <a href="#rid41">
          41,42
         </a>
         ]. Careful review of the CT scan is needed to ensure that the suspected abscess is not an infected bulla, since the risk of pneumothorax with needle aspiration may be high. Pneumothorax and pleural seeding appear less likely to occur if the abscess abuts the pleura and the needle or catheter can be passed through an area of pleural thickening into the cavity. Transthoracic drainage of lung abscess is described below. (See
         <a class="local">
          'Needle or catheter drainage'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Echocardiography
         </strong>
         – For patients with multiple lung abscesses, transthoracic echocardiography is advised to assess for right-sided valve infective endocarditis [
         <a href="#rid43">
          43-46
         </a>
         ]. If transthoracic echocardiography is negative when the suspicion for endocarditis is high, a transesophageal echocardiogram should be performed. (See
         <a class="medical medical_review" href="/z/d/html/2149.html" rel="external">
          "Right-sided native valve infective endocarditis", section on 'Cardiac imaging'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Thoracentesis
         </strong>
         – If pleural fluid is present on the chest radiograph, a thoracentesis is performed to obtain a sample for microbiologic testing and to exclude empyema (fluid appearance, cell count and differential, chemistries including LDH and glucose, pH). (See
         <a class="medical medical_review" href="/z/d/html/6702.html" rel="external">
          "Epidemiology, clinical presentation, and diagnostic evaluation of parapneumonic effusion and empyema in adults", section on 'Thoracentesis and pleural fluid analysis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Transtracheal aspiration
         </strong>
         - While popular in the past, transtracheal aspiration is no longer performed due to safety concerns. [
         <a href="#rid36">
          36,47-49
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6986.html" rel="external">
          "Diagnostic evaluation of the incidental pulmonary nodule", section on 'Transthoracic needle biopsy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3041380119">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of lung abscess is a clinical one, based on the radiographic appearance (most often one or more cavities with an air-fluid interface), supportive clinical features and microbiologic tests, and response to antimicrobial therapy. Clinicians should understand that in many cases, (approximately half), the offending pathogen is not isolated [
         <a href="#rid17">
          17,18
         </a>
         ].
        </p>
        <p>
         For patients with lung abscess without a clear predisposing factor, post-diagnostic testing may be appropriate to assess for dysphagia, episodes of altered consciousness, underlying bronchiectasis, or immune deficits.
        </p>
        <p class="headingAnchor" id="H3774257884">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The key processes to consider in the differential diagnosis of lung abscess are other causes of a fluid or air-fluid filled mass in the lung parenchyma (eg, lung cancer, granulomatosis with polyangiitis [GPA], infected lung cyst or bulla, hydatid cyst, or superinfected fungal or mycobacterial cavity)  (
         <a class="graphic graphic_table graphicRef67943" href="/z/d/graphic/67943.html" rel="external">
          table 2
         </a>
         ). Additionally, an empyema with an air-fluid interface can mimic a lung abscess on conventional chest radiographs. While less common in adults, intralobar pulmonary sequestrations can develop abscesses.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Malignancy
         </strong>
         – Primary lung cancer and metastatic cancer can present with cavitary lesions that mimic lung abscess or become superinfected. Additionally, endobronchial cancer can cause a postobstructive lung abscess. A solitary thick-walled cavity (wall &gt;15 mm diameter) without surrounding consolidation is concerning for lung cancer. Diagnostic cytology and/or biopsy are warranted if the patient does not have systemic features suggestive of infection (fever, productive cough, leukocytosis) or if the lesion fails to improve despite antibiotics. Note, however, that endobronchial tumor can lead to postobstructive pneumonia and lung abscess, so it is possible for both malignancy and infection to be present. (See
         <a class="medical medical_review" href="/z/d/html/4632.html" rel="external">
          "Overview of the initial evaluation, diagnosis, and staging of patients with suspected lung cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Noninfectious granulomatous disease
         </strong>
         – Several noninfectious granulomatous and inflammatory diseases form cavitating lung nodules, such as GPA [
         <a href="#rid50">
          50
         </a>
         ], rheumatoid arthritis, sarcoidosis, nodular silicosis, and pulmonary Langerhans cell histiocytosis. (See
         <a class="medical medical_review" href="/z/d/html/4353.html" rel="external">
          "Clinical manifestations and diagnosis of sarcoidosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4330.html" rel="external">
          "Granulomatosis with polyangiitis and microscopic polyangiitis: Respiratory tract involvement", section on 'Computed tomography'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4380.html" rel="external">
          "Overview of pleuropulmonary diseases associated with rheumatoid arthritis", section on 'Rheumatoid lung nodules'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4321.html" rel="external">
          "Silicosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4334.html" rel="external">
          "Pulmonary Langerhans cell histiocytosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tuberculosis with or without bacterial superinfection
         </strong>
         – Postprimary
         <em>
          Mycobacterium tuberculosis
         </em>
         in the lung is associated with thin-walled cavities or cavities on a background of patchy airspace opacity. An air-fluid interface may be present in the cavity in as many as 20 percent of cases, due to bleeding or bacterial superinfection [
         <a href="#rid51">
          51,52
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7026.html" rel="external">
          "Pulmonary tuberculosis: Clinical manifestations and complications", section on 'Radiologic findings'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chronic pulmonary aspergillosis
         </strong>
         – Chronic cavitary aspergillosis can present with several months of weight loss, productive cough, hemoptysis of variable severity, shortness of breath, and sometimes fever. Cavities may contain fungus balls, debris, or fluid, and the walls are usually thin. Aspergillus antibody (precipitins) is elevated in over 90 percent of patients. (See
         <a class="medical medical_review" href="/z/d/html/2441.html" rel="external">
          "Chronic pulmonary aspergillosis: Epidemiology, clinical manifestations and diagnosis", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hydatid cyst
         </strong>
         – For patients with travel or residence in an area endemic for
         <em>
          Echinococcus
         </em>
         , computed tomography (CT) imaging can identify single or multilocular cysts that may have an air crescent sign, germinative membranes floating in cyst fluid (water lily sign), or are empty. Liver cysts are also present in about 20 percent of patients with lung cysts and provide an etiologic clue. Peripheral blood eosinophilia is uncommon and serologic tests are variably helpful. (See
         <a class="medical medical_review" href="/z/d/html/5669.html" rel="external">
          "Echinococcosis: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Empyema with air-fluid interface
         </strong>
         – It can sometimes be difficult to determine from a chest radiograph whether an air-fluid interface is in the pleural space or lung parenchyma. Empyema can be associated with chest pain, but a lung abscess abutting the pleura can also cause chest pain. Chest CT is the procedure of choice for making this differentiation and guiding therapy. Abscesses tend to be more irregular in shape, spherical, and cavitated whereas empyemas tend to be better defined, elliptical, homogeneous, and have a smooth and uniform wall. Empyema may displace the blood vessels leading from the hilum to the periphery whereas abscesses typically do not. Empyemas will need to be drained via chest tube. (See
         <a class="medical medical_review" href="/z/d/html/6702.html" rel="external">
          "Epidemiology, clinical presentation, and diagnostic evaluation of parapneumonic effusion and empyema in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/119384.html" rel="external">
          "Management and prognosis of parapneumonic pleural effusion and empyema in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infected sequestration
         </strong>
         – Infection is a well-described complication of pulmonary intralobar sequestration and may undergo abscess formation [
         <a href="#rid53">
          53-55
         </a>
         ]. Diagnosis of sequestration is important because sequestration infections tend to be recurrent and generally require surgical resection. (See
         <a class="medical medical_review" href="/z/d/html/6341.html" rel="external">
          "Bronchopulmonary sequestration"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h1">
          TREATMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Treatment of lung abscess is based on prompt initiation of an empiric antibiotic regimen, adjustment of the regimen based on culture results, and a prolonged course of therapy  (
         <a class="graphic graphic_algorithm graphicRef133181" href="/z/d/graphic/133181.html" rel="external">
          algorithm 1
         </a>
         ). This approach is successful in most patients, while a few require a drainage procedure or surgical resection (about 10 percent).
        </p>
        <p>
         The role of postural drainage and chest percussion (chest physiotherapy) is less clear; it has been used with the rationale that it would facilitate intrabronchial drainage [
         <a href="#rid32">
          32
         </a>
         ]. However, efficacy has not been demonstrated and fatal cases of intrabronchial abscess rupture have been reported. We reserve cautious chest physiotherapy for patients with cystic fibrosis and noncystic fibrosis bronchiectasis who are on a routine program of bronchial hygiene.
        </p>
        <p class="headingAnchor" id="H2989421254">
         <span class="h2">
          Initial empiric antibiotics
         </span>
         <span class="headingEndMark">
          —
         </span>
         Empiric antimicrobial therapy should be started promptly in patients with lung abscess to reduce the risk of abscess rupture into the airways or pleural space or invasion of local structures (eg, blood vessels). The initial regimen can be adjusted, if needed, based on culture results and response to therapy, remembering that anaerobic organisms are difficult to grow in culture and susceptibility testing is rarely performed.
        </p>
        <p>
         For patients with suspected lung abscess from aspiration, empiric intravenous (IV) regimens should penetrate the lung parenchyma and target both strict anaerobes and microaerophilic streptococci.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For most patients, acceptable regimens include any combination of a beta-lactam–beta-lactamase inhibitor (eg,
         <a class="drug drug_general" data-topicid="8745" href="/z/d/drug information/8745.html" rel="external">
          ampicillin-sulbactam
         </a>
         3 g intravenously [IV] every six hours) or a carbapenem (eg,
         <a class="drug drug_general" data-topicid="8553" href="/z/d/drug information/8553.html" rel="external">
          imipenem
         </a>
         ,
         <a class="drug drug_general" data-topicid="9613" href="/z/d/drug information/9613.html" rel="external">
          meropenem
         </a>
         ). This choice is based upon
         <em>
          in vitro
         </em>
         data, our experience, and the increasing rates of penicillin-resistance among anaerobes includi
         <em>
          ng Bacteroides ruminicola
         </em>
         , black-pigmenting strains
         <em>
          of Prevotella
         </em>
         (formal
         <em>
          ly Bacteroides melaninogenicus
         </em>
         group
         <em>
          ), Bacteroides gracilis, Bacteroides ureolyticus
         </em>
         , Fusobacteria, and others [
         <a href="#rid14">
          14,56-59
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/482.html" rel="external">
          "Combination beta-lactamase inhibitors, carbapenems, and monobactams"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients who are allergic to penicillin, we generally use
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         400 mg orally daily [
         <a href="#rid19">
          19,60
         </a>
         ], or combination therapy with
         <a class="drug drug_general" data-topicid="9554" href="/z/d/drug information/9554.html" rel="external">
          levofloxacin
         </a>
         (750 mg orally daily) plus
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         (500 mg orally three times daily). For hospitalized patients,
         <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">
          ceftriaxone
         </a>
         (or other third-generation cephalosporin) plus metronidazole is a reasonable option. For outpatients who are allergic to penicillin, we favor a fluoroquinolone-based regimen when starting treatment because these regimens have better bioavailability.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          Clindamycin
         </a>
         monotherapy (600 mg IV every eight hours followed by 300 mg orally four times daily) is also a potential alternative [
         <a href="#rid61">
          61,62
         </a>
         ]. However, clindamycin has the potential to fail, as abscesses are caused by gram negatives or resistant gram positives in 20 to 30 percent of patients [
         <a href="#rid16">
          16,19,20
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Adjusting antimicrobial regimen
         </span>
         <span class="headingEndMark">
          —
         </span>
         Once culture results are available, empiric antimicrobial therapy can be tailored to cover identified pathogens, although the empiric regimens described above remain appropriate for most patients with aspiration-related mixed anaerobic and streptococcal lung abscess (see
         <a class="local">
          'Initial empiric antibiotics'
         </a>
         above). When a single pathogen that is not a typical part of the oral flora is detected (eg,
         <em>
          K. pneumoniae
         </em>
         ,
         <em>
          S. aureus
         </em>
         ), it is often appropriate to tailor the regimen to target that pathogen based upon the results of
         <em>
          in vitro
         </em>
         susceptibility testing. However, as culture of anaerobes from the lung is difficult, continuing empiric anaerobic coverage in addition may be prudent, particularly in patients with suspected aspiration who have putrid sputum.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For suspected methicillin-susceptible
         <em>
          S. aureus
         </em>
         (MSSA), the agents of choice are
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         (2 g IV every eight hours),
         <a class="drug drug_general" data-topicid="9674" href="/z/d/drug information/9674.html" rel="external">
          nafcillin
         </a>
         (2 g IV every four hours), or
         <a class="drug drug_general" data-topicid="9724" href="/z/d/drug information/9724.html" rel="external">
          oxacillin
         </a>
         (2 g IV every four hours).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For methicillin-resista
         <em>
          nt S. aureus
         </em>
         (MRSA),
         <a class="drug drug_general" data-topicid="10283" href="/z/d/drug information/10283.html" rel="external">
          linezolid
         </a>
         (600 mg IV every 12 hours) or
         <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">
          vancomycin
         </a>
         are acceptable  (
         <a class="graphic graphic_table graphicRef128911" href="/z/d/graphic/128911.html" rel="external">
          table 3
         </a>
         ) [
         <a href="#rid63">
          63
         </a>
         ]. Other options are
         <a class="drug drug_general" data-topicid="16088" href="/z/d/drug information/16088.html" rel="external">
          ceftaroline
         </a>
         ,
         <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">
          trimethoprim-sulfamethoxazole
         </a>
         , and
         <a class="drug drug_general" data-topicid="9535" href="/z/d/drug information/9535.html" rel="external">
          telavancin
         </a>
         . Ceftaroline is active in vitro against virtually all strains of MRSA [
         <a href="#rid64">
          64
         </a>
         ], but it has not been approved by the US Food and Drug Administration (FDA) for MRSA pneumonia because of limited data on using it for this indication [
         <a href="#rid65">
          65,66
         </a>
         ].
         <a class="drug drug_general" data-topicid="9304" href="/z/d/drug information/9304.html" rel="external">
          Daptomycin
         </a>
         should
         <strong>
          not
         </strong>
         be used for pulmonary infections due to inadequate activity in the lung [
         <a href="#rid67">
          67
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6993.html" rel="external">
          "Treatment of hospital-acquired and ventilator-associated pneumonia in adults", section on 'Methicillin-resistant S. aureus'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3906626940">
         <span class="h2">
          Duration of antibiotics
         </span>
         <span class="headingEndMark">
          —
         </span>
         In general, we switch from IV to oral agents once the patient has defervesced and become clinically stable; for some patients this takes a few days while in others it may be one to three weeks. Appropriate oral regimens depend upon the identified or suspected infecting pathogens. For patients with a mixed anaerobic and streptococcal infection,
         <a class="drug drug_general" data-topicid="8676" href="/z/d/drug information/8676.html" rel="external">
          amoxicillin-clavulanate
         </a>
         is an appropriate regimen [
         <a href="#rid68">
          68
         </a>
         ], but the choice of regimen should be guided by the causative pathogen(s) and susceptibility results when available.
        </p>
        <p>
         The optimal total duration of therapy (IV plus oral) is unknown; reported ranges include 21 to 48 days [
         <a href="#rid1">
          1,17
         </a>
         ]. Some experts treat for three weeks as a standard and others treat based upon the response. Our practice is to continue antibiotic treatment until chest imaging (preferably computed tomography [CT]) shows a small, stable residual lesion or is clear. This generally requires several weeks of treatment, most of which can be accomplished with an oral regimen on an outpatient basis.
        </p>
        <p class="headingAnchor" id="H2617087001">
         <span class="h2">
          Response to therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most patients are followed clinically, but repeat imaging is prudent for new onset or recurrent fevers, chest pain, hemoptysis, dyspnea, or failure to improve.
        </p>
        <p>
         Patients with aspiration-related lung abscesses usually show clinical improvement with decreased fever and leukocytosis within three to four days after beginning antibiotic treatment. Defervescence is expected in 7 to 10 days [
         <a href="#rid9">
          9,10,69-71
         </a>
         ]. The disappearance of putrid sputum may take longer.
        </p>
        <p>
         Persistent fevers beyond one to two weeks may indicate delayed response, and such patients should undergo further diagnostic tests to better define the underlying anatomy and microbiology of the infection; typically, another chest CT is performed to look for progression of the abscess, development of complications (eg, empyema or new abscesses), or an underlying precipitant that may not have been picked up on the initial CT scan  (
         <a class="graphic graphic_algorithm graphicRef133181" href="/z/d/graphic/133181.html" rel="external">
          algorithm 1
         </a>
         ). In addition, further respiratory sampling via flexible bronchoscopy is usually indicated. (See
         <a class="local">
          'Additional testing'
         </a>
         above.)
        </p>
        <p>
         Major considerations in patients with a delayed response include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         An associated condition that precludes response, such as obstruction with a foreign body or neoplasm, or a pulmonary sequestration.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Erroneous microbiologic diagnosis with infection due to bacteria, mycobacteria, or fungi that are not being treated.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Failure of medical therapy despite appropriate antibiotics. Drainage may be required to facilitate recovery. This is more typical in patients with large cavities but there is no clear size cut-off that mandates intervention, and drainage has been reported to be helpful even for some smaller abscesses that fail to improve with antibiotics [
         <a href="#rid38">
          38,72-75
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         An alternative, nonbacterial cause of cavitary lung disease, such as cavitating neoplasm, vasculitis. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Conditions that mimic an abscess such as an infected cyst or empyema. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other causes of persistent fever, such as drug fever or
         <em>
          Clostridioides difficile
         </em>
         –associated colitis. (See
         <a class="medical medical_review" href="/z/d/html/2738.html" rel="external">
          "Drug fever"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2699.html" rel="external">
          "
          <i>
           Clostridioides difficile
          </i>
          infection in adults: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Patients who fail to improve by 7 to 10 days despite appropriate antimicrobial therapy may need a drainage procedure or surgery. (See
         <a class="local">
          'Failure of antimicrobial therapy'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1902702790">
         <span class="h2">
          Failure of antimicrobial therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most lung abscesses respond to a prolonged course of antimicrobials. However, a small proportion fail antimicrobials and require a drainage procedure or surgical therapy (approximately 10 percent) [
         <a href="#rid76">
          76,77
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2752298861">
         <span class="h3">
          Needle or catheter drainage
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients who fail to improve after 7 to 10 days of antibiotic therapy that has been adjusted based on microbiologic results, drainage of the abscess via transthoracic or transbronchial catheters can often lead to clinical improvement [
         <a href="#rid38">
          38,72,73,78-85
         </a>
         ]. Among these options, percutaneous drainage is preferred since experience with this option is more extensive than with bronchoscopic drainage. Patients continue with their systemic antimicrobial until the abscess cavity closes or is small and stable. The typical duration of drainage catheter placement is approximately three days to three weeks and patients generally continue with their systemic antimicrobial.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Transthoracic (percutaneous) catheter drainage
         </strong>
         – Transthoracic (percutaneous) catheter drainage can be performed under imaging guidance; depending on the available facilities, computed tomography, ultrasound, or fluoroscopy may be utilized [
         <a href="#rid74">
          74,85
         </a>
         ]. The transthoracic route is generally preferred when the abscess abuts or is close to the chest wall.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Transthoracic drainage procedures carry a small risk of infecting the pleural space. In addition, they are also associated with a small risk of hemorrhage or pneumothorax.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Transbronchoscopic catheter drainage
         </strong>
         – The bronchoscopic approach may be preferred for more centrally located lesions and for those that do not abut the pleura; ultrasound-guided bronchoscopy may be used for localization [
         <a href="#rid38">
          38,72,73
         </a>
         ]. Bronchoscopic drainage is performed by placing a pigtail catheter into the abscess cavity via the nose under bronchoscopic visualization, leaving the catheter in place until the cavity has drained [
         <a href="#rid72">
          72
         </a>
         ]. In some cases, the cavity is rinsed daily with sterile
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         and directed antibiotics (eg,
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          gentamicin
         </a>
         or antifungal).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         One of the risks associated with bronchoscopic drainage is spillage of infected material to other parts of the lung. Intracavitary fibrinolytic therapy is not recommended due to the potential development of a bronchopleural fistula. This procedure is not universally available and is restricted to centers with pulmonary interventional expertise. Bronchoscopy for drainage, in the absence of catheter placement, is of little use and can result in spillage of abscess contents into other airways [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2405177077">
         <span class="h3">
          Treating endobronchial obstruction
         </span>
         <span class="headingEndMark">
          —
         </span>
         For postobstructive lung abscess due to bronchial stenosis or tumor, efforts should be directed at relieving the obstruction or possibly curative surgical resection of the tumor (typically lobectomy)  (
         <a class="graphic graphic_algorithm graphicRef133181" href="/z/d/graphic/133181.html" rel="external">
          algorithm 1
         </a>
         ). Foreign body removal is often achieved with flexible or rigid bronchoscopy. For bronchial stenosis or tumor, endobronchial balloon dilation with stent placement may be an option pending definitive therapy. Obstruction from mediastinal lesions (eg, aneurysms or lymphadenopathy) require individualized assessment and treatment. The management of airway obstruction is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4384.html" rel="external">
          "Clinical presentation, diagnostic evaluation, and management of malignant central airway obstruction in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4402.html" rel="external">
          "Flexible bronchoscopy balloon dilation for nonmalignant airway strictures (bronchoplasty)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4403.html" rel="external">
          "Airway stents"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h3">
          Surgical intervention
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients who fail to improve clinically or radiographically with antibiotic therapy with or without catheter drainage or who develop complications during therapy (eg, significant hemorrhage, bronchopleural fistula), surgery may very rarely be indicated.
        </p>
        <p>
         Factors that may contribute to a slow response or no response are obstruction of the bronchus, an extremely large size abscess, and abscesses involving antibiotic-resistant organisms, such as
         <em>
          P. aeruginosa
         </em>
         .
        </p>
        <p>
         The usual procedure in such cases is a lobectomy or pneumonectomy but small peripheral abscesses may be amenable to segmentectomy or wedge resection [
         <a href="#rid86">
          86
         </a>
         ]. Video-assisted thoracic surgery (VATS) is the procedure of choice and attention should be paid to removing all infected material in order to avoid stump infection and resultant bronchopleural fistula [
         <a href="#rid87">
          87
         </a>
         ].
        </p>
        <p>
         Mortality with surgery is as high as 15 to 20 percent although the high mortality rate likely reflects the severity of lung abscess in patients referred for lung surgery as well as their underlying conditions, in addition to the risk of surgery itself [
         <a href="#rid88">
          88,89
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h1">
          OUTCOMES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with primary lung abscess (about 60 percent overall) with typical aspiration-related lung abscesses, including those with alcohol or injection drug use, generally do well with antibiotic treatment with cure rates of 90 to 95 percent [
         <a href="#rid1">
          1,10,17,24,32,74,90
         </a>
         ]. Patients who require surgery, are immunocompromised, or have malignancy or irreversible bronchial obstruction have higher mortality rates [
         <a href="#rid91">
          91
         </a>
         ]. Associated disease in the host is an important factor in determining the outcome of a lung abscess.
        </p>
        <p>
         In one illustrative series of 252 patients with aspiration lung abscess, antibiotic therapy (mainly penicillin and
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         ) was successful in 200 [
         <a href="#rid32">
          32
         </a>
         ]. Drainage of the abscess was performed in 6 patients, drainage of empyema in 24, and pulmonary resection in 22. There were 10 deaths.
        </p>
        <p class="headingAnchor" id="H28232653">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/118986.html" rel="external">
          "Society guideline links: Hemoptysis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6668219">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/16957.html" rel="external">
          "Patient education: Aspiration pneumonia (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1232496574">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition
         </strong>
         – Lung abscess is defined as a circumscribed area of pus or necrosis in the pulmonary parenchyma caused by microbial infection. While most lung abscesses are single, the term "necrotizing pneumonia" or "lung gangrene" may be used to describe necrosis with multiple small abscesses within an area of pneumonia. (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Definitions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pathogenesis
         </strong>
         – Aspiration is the most common cause of lung abscesses, accounting for approximately 80 percent of cases. Less commonly, lung abscesses arise as complications of pneumonia caused by pyogenic bacteria (eg,
         <em>
          Klebsiella pneumoniae
         </em>
         ,
         <em>
          S. aureus
         </em>
         ). Other mechanisms include septic emboli from tricuspid valve endocarditis, other forms of hematogenous spread (eg, Lemierre syndrome), direct extension (eg, traumatic inoculation), and endobronchial obstruction. (See
         <a class="local">
          'Pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microbiology
         </strong>
         – Lung abscesses that result from aspiration are typically polymicrobial, composed of the oral flora that inhabits the gingival crevices. This flora typically includes microaerophilic streptococci and anaerobes (
         <em>
          Peptostreptococcus, Prevotella, Bacteroides
         </em>
         [usually n
         <em>
          ot B. fragilis]
         </em>
         ), a
         <em>
          nd Fusobacterium
         </em>
         spp  (
         <a class="graphic graphic_table graphicRef62555" href="/z/d/graphic/62555.html" rel="external">
          table 4
         </a>
         ), but Gram-negative organisms are also seen, particularly in immunocompromised patients and patients with multiple comorbidities. (See
         <a class="local">
          'Microbiologic testing'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features
         </strong>
         – Classically, the onset of illness associated with lung abscesses is indolent, with symptoms arising over weeks to months. Typical symptoms include cough (often with putrid-smelling sputum), dyspnea, and/or chest pain. Systemic symptoms can include fever, chills, night sweats and weight loss. (See
         <a class="local">
          'Clinical features'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnostic evaluation
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Imaging
         </strong>
         – For most patients, the diagnosis can be made based on radiographic findings in a patient with compatible clinical features (eg, history of aspiration). Chest radiograph typically shows a thick-walled cavity with an air-fluid level, with or without a surrounding opacity  (
         <a class="graphic graphic_diagnosticimage graphicRef79327" href="/z/d/graphic/79327.html" rel="external">
          image 1
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef54525" href="/z/d/graphic/54525.html" rel="external">
          image 2
         </a>
         ). We typically obtain a chest CT to better characterize the extent and possible cause of lung abscesses  (
         <a class="graphic graphic_diagnosticimage graphicRef79327" href="/z/d/graphic/79327.html" rel="external">
          image 1
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef54525" href="/z/d/graphic/54525.html" rel="external">
          image 2
         </a>
         ). (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Diagnostic testing
         </strong>
         – In all patients, we obtain sputum Gram stain, sputum culture, and blood cultures to help direct therapy. More invasive testing (eg, bronchoscopy or percutaneous needle aspiration of the abscess) is usually reserved for cases in which there is diagnostic uncertainty, clinical instability, suspicion for unusual pathogen, and/or when patients are not responding to empiric therapy. (See
         <a class="local">
          'Diagnostic evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – The differential diagnosis includes other forms of infectious cavitary lung disease (eg, necrotizing pneumonia, nocardiosis, tuberculosis, septic emboli) and noninfectious cavitary lung disease (eg, malignancy, pulmonary vasculitides)  (
         <a class="graphic graphic_table graphicRef67943" href="/z/d/graphic/67943.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Typical empiric therapy
         </strong>
         – For patients with suspected lung abscess from aspiration, empiric antibiotics that penetrate the lung parenchyma and target both strict anaerobes and facultatively anaerobic streptococci should be chosen  (
         <a class="graphic graphic_algorithm graphicRef133181" href="/z/d/graphic/133181.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="local">
          'Initial empiric antibiotics'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We suggest a beta-lactam with a beta-lactamase inhibitor for most patients (eg,
         <a class="drug drug_general" data-topicid="8745" href="/z/d/drug information/8745.html" rel="external">
          ampicillin-sulbactam
         </a>
         3 g intravenously [IV] every six hours) or a carbapenem (eg,
         <a class="drug drug_general" data-topicid="8553" href="/z/d/drug information/8553.html" rel="external">
          imipenem
         </a>
         ,
         <a class="drug drug_general" data-topicid="9613" href="/z/d/drug information/9613.html" rel="external">
          meropenem
         </a>
         ) because of rising penicillin resistance rates among anaerobes (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients who cannot use beta-lactams, we typically use
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         alone, or combination therapy with
         <a class="drug drug_general" data-topicid="9554" href="/z/d/drug information/9554.html" rel="external">
          levofloxacin
         </a>
         plus
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         .
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Most patients with a lung abscess caused by aspiration will recover with antibiotic treatment alone. The duration of treatment varies based on clinical and radiographic response. Generally, we assess response (symptoms, fevers, leukocytosis) after 7 to 10 days of antibiotic treatment. In those who respond, we continue antibiotic treatment until chest imaging shows a small, stable residual lesion or is clear. This generally requires several weeks of outpatient therapy. (See
         <a class="local">
          'Duration of antibiotics'
         </a>
         above and
         <a class="local">
          'Response to therapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Special populations
         </strong>
         – Modifications to this regimen (eg, broader empiric therapy) may be needed for patients with clinical instability, immunocompromised patients, and/or when specific pathogens are suspected based on clinical or radiographic features (eg, coverage for
         <em>
          S. aureus
         </em>
         or
         <em>
          Pseudomonas
         </em>
         in a patient with necrotizing pneumonia). (See
         <a class="local">
          'Initial empiric antibiotics'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management of endobronchial obstruction
         </strong>
         – If there is concurrent endobronchial obstruction (eg, due to tumor, stenosis, foreign body), that obstruction should be relieved when possible (eg, tumor resection/cytoreduction, stenting for bronchial stenosis, or foreign body removal). (See
         <a class="local">
          'Treating endobronchial obstruction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Failure of antimicrobial therapy
         </strong>
         – For patients who do not improve despite antibiotic treatment, abscess drainage is indicated. When the abscess is accessible percutaneously, we prefer transthoracic drainage over transbronchial catheter drainage because it is technically easier and the risk of endobronchial spread of infection is less. Surgical resection is rarely necessary and reserved for those with abscesses that cannot be drained or do not respond to drainage with less invasive approaches. (See
         <a class="local">
          'Failure of antimicrobial therapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1575547712">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate gratefully acknowledges John G Bartlett, MD (deceased), who contributed as author on earlier versions of this topic and was a founding Editor-in-Chief for UpToDate in Infectious Diseases.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Kuhajda I, Zarogoulidis K, Tsirgogianni K, et al. Lung abscess-etiology, diagnostic and treatment options. Ann Transl Med 2015; 3:183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pennza PT. Aspiration pneumonia, necrotizing pneumonia, and lung abscess. Emerg Med Clin North Am 1989; 7:279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chung G, Goetz MB. Anaerobic Infections of the Lung. Curr Infect Dis Rep 2000; 2:238.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valvani A, Martin A, Devarajan A, Chandy D. Postobstructive pneumonia in lung cancer. Ann Transl Med 2019; 7:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hsu-Kim C, Hoag JB, Cheng GS, Lund ME. The microbiology of postobstructive pneumonia in lung cancer patients. J Bronchology Interv Pulmonol 2013; 20:266.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rolston KVI, Nesher L. Post-Obstructive Pneumonia in Patients with Cancer: A Review. Infect Dis Ther 2018; 7:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edwards P, Brener M, Isles A, Kapur N. Staphylococcal lung abscess in a child with cystic fibrosis: Case report &amp; review of literature. Respir Med Case Rep 2020; 29:101024.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Canny GJ, Marcotte JE, Levison H. Lung abscess in cystic fibrosis. Thorax 1986; 41:221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bartlett JG, Gorbach SL, Tally FP, Finegold SM. Bacteriology and treatment of primary lung abscess. Am Rev Respir Dis 1974; 109:510.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bartlett JG. Treatment of anaerobic pleuropulmonary infections. Ann Intern Med 1975; 83:376.
          </a>
         </li>
         <li class="breakAll">
          Beerens H, Tahon-Castel M.. Infections humaines a bacteries anaerobies non toxigenes., Presses Academiques Europeennes, Brussels 1965. p.91.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bartlett JG, Finegold SM. Anaerobic infections of the lung and pleural space. Am Rev Respir Dis 1974; 110:56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clinical conferences at the Johns Hopkins Hospital: lung abscess. Johns Hopkins Med J 1982; 150:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perlman LV, Lerner E, D'Esopo N. Clinical classification and analysis of 97 cases of lung abscess. Am Rev Respir Dis 1969; 99:390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bartlett JG. Anaerobic bacterial infections of the lung. Chest 1987; 91:901.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang JL, Chen KY, Fang CT, et al. Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes. Clin Infect Dis 2005; 40:915.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Takayanagi N, Kagiyama N, Ishiguro T, et al. Etiology and outcome of community-acquired lung abscess. Respiration 2010; 80:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mukae H, Noguchi S, Naito K, et al. The Importance of Obligate Anaerobes and the Streptococcus anginosus Group in Pulmonary Abscess: A Clone Library Analysis Using Bronchoalveolar Lavage Fluid. Respiration 2016; 92:80.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ott SR, Allewelt M, Lorenz J, et al. Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess. Infection 2008; 36:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allewelt M, Schüler P, Bölcskei PL, et al. Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess. Clin Microbiol Infect 2004; 10:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           FISHER AM, TREVER RW, CURTIN JA, et al. Staphylococcal pneumonia; a review of 21 cases in adults. N Engl J Med 1958; 258:919.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Madhani K, McGrath E, Guglani L. A 10-year retrospective review of pediatric lung abscesses from a single center. Ann Thorac Med 2016; 11:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bullowa JG, Chess J, Friedman NJ. Pneumonia due to Bacillus friedlanderi. Arch Intern Med 1937; 60:735.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mohapatra MM, Rajaram M, Mallick A. Clinical, Radiological and Bacteriological Profile of Lung Abscess - An Observational Hospital Based Study. Open Access Maced J Med Sci 2018; 6:1642.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams DM, Krick JA, Remington JS. Pulmonary infection in the compromised host: part I. Am Rev Respir Dis 1976; 114:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keefer CS, Ingelfinger FJ, Spink WW. Significance of hemolytic streptococci bacteremia: Study of 246 patients. Arch Intern Med 1937; 60:1084.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Howe C, Sampath A, Spotnitz M. The pseudomallei group: a review. J Infect Dis 1971; 124:598.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peetermans WE, Van Wijngaerden E, Van Eldere J, Verhaegen J. Melioidosis brain and lung abscess after travel to Sri Lanka. Clin Infect Dis 1999; 28:921.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Senécal JL, St-Antoine P, Béliveau C. Legionella pneumophila lung abscess in a patient with systemic lupus erythematosus. Am J Med Sci 1987; 293:309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           La Scola B, Michel G, Raoult D. Isolation of Legionella pneumophila by centrifugation of shell vial cell cultures from multiple liver and lung abscesses. J Clin Microbiol 1999; 37:785.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leatherman JW, Iber C, Davies SF. Cavitation in bacteremic pneumococcal pneumonia. Causal role of mixed infection with anaerobic bacteria. Am Rev Respir Dis 1984; 129:317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moreira Jda S, Camargo Jde J, Felicetti JC, et al. Lung abscess: analysis of 252 consecutive cases diagnosed between 1968 and 2004. J Bras Pneumol 2006; 32:136.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neild JE, Eykyn SJ, Phillips I. Lung abscess and empyema. Q J Med 1985; 57:875.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jerng JS, Hsueh PR, Teng LJ, et al. Empyema thoracis and lung abscess caused by viridans streptococci. Am J Respir Crit Care Med 1997; 156:1508.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stark DD, Federle MP, Goodman PC, et al. Differentiating lung abscess and empyema: radiography and computed tomography. AJR Am J Roentgenol 1983; 141:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bartlett JG. Diagnostic accuracy of transtracheal aspiration bacteriologic studies. Am Rev Respir Dis 1977; 115:777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williford ME, Godwin JD. Computed tomography of lung abscess and empyema. Radiol Clin North Am 1983; 21:575.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Takaki M, Tsuyama N, Ikeda E, et al. The Transbronchial Drainage of a Lung Abscess Using Endobronchial Ultrasonography with a Modified Guide Sheath. Intern Med 2019; 58:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McDill H, Hassan M, Dack G, et al. To drain or not to drain? Abscess or empyema? Thorax 2021; 76:313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hammer DL, Aranda CP, Galati V, Adams FV. Massive intrabronchial aspiration of contents of pulmonary abscess after fiberoptic bronchoscopy. Chest 1978; 74:306.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang M, Zhang XY, Chen YB. Primary pulmonary actinomycosis: a retrospective analysis of 145 cases in mainland China. Int J Tuberc Lung Dis 2017; 21:825.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vargas Puerto A, Peña Griñan N, Muñoz Lucena F, et al. [Usefulness of transthoracic pulmonary aspiration biopsy in lung abscess secondary to neoplasm]. Arch Bronconeumol 1996; 32:132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheng YF, Hsieh YK, Wang BY, et al. Tricuspid valve infective endocarditis complicated with multiple lung abscesses and thoracic empyema as different pathogens: a case report. J Cardiothorac Surg 2019; 14:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garbati MA, Tleyjeh IM, Abba AA. Complicated community-acquired Staphylococcus endocarditis and multiple lung abscesses: case report and review of literature. Case Rep Infect Dis 2011; 2011:981316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fujino T, Amari Y, Mohri M, et al. MRSA tricuspid valve infective endocarditis with multiple embolic lung abscesses treated by combination therapy of vancomycin, rifampicin, and sulfamethoxazole/trimethoprim. J Cardiol 2009; 53:146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Que YA, Muller O, Liaudet L. Images in cardiovascular medicine. Rapid resolution of massive lung abscesses complicating tricuspid-valve endocarditis. Circulation 2006; 114:e523.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bartlett JG. The technique of transtracheal aspiration. J Crit Illn 1986; 1:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bandt PD, Blank N, Castellino RA. Needle diagnosis of pneumonitis. Value in high-risk patients. JAMA 1972; 220:1578.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pratter MR, Irwin RS. Transtracheal aspiration. Guidelines for safety. Chest 1979; 76:518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Russell B, Mohan S, Chahal R, et al. Prognostic Significance of Cavitary Lung Nodules in Granulomatosis With Polyangiitis (Wegener's): A Clinical Imaging Study of 225 Patients. Arthritis Care Res (Hoboken) 2018; 70:1082.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen JR, Amorosa JK, Smith PR. The air-fluid level in cavitary pulmonary tuberculosis. Radiology 1978; 127:315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barnes PF, Verdegem TD, Vachon LA, et al. Chest roentgenogram in pulmonary tuberculosis. New data on an old test. Chest 1988; 94:316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polaczek M, Baranska I, Szolkowska M, et al. Clinical presentation and characteristics of 25 adult cases of pulmonary sequestration. J Thorac Dis 2017; 9:762.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ali A, Abdel-Aziz Y, Yoon Y. A Rare Case of Bronchopulmonary Sequestration Masquerading as Lung Abscess. Am J Med Sci 2019; 358:e23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gompelmann D, Eberhardt R, Heussel CP, et al. Lung sequestration: a rare cause for pulmonary symptoms in adulthood. Respiration 2011; 82:445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldstein EJ, Citron DM, Warren Y, et al. In vitro activity of gemifloxacin (SB 265805) against anaerobes. Antimicrob Agents Chemother 1999; 43:2231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Finegold SM, George WL, Mulligan ME. Anaerobic infections. Part II. Dis Mon 1985; 31:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Finegold SM, Rolfe RD. Susceptibility testing of anaerobic bacteria. Diagn Microbiol Infect Dis 1983; 1:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Appelbaum PC, Spangler SK, Jacobs MR. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers. Antimicrob Agents Chemother 1990; 34:1546.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polenakovik H, Burdette SD, Polenakovik S. Moxifloxacin is efficacious for treatment of community-acquired lung abscesses in adults. Clin Infect Dis 2005; 41:764.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levison ME, Mangura CT, Lorber B, et al. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med 1983; 98:466.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gudiol F, Manresa F, Pallares R, et al. Clindamycin vs penicillin for anaerobic lung infections. High rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus. Arch Intern Med 1990; 150:2525.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wunderink RG, Niederman MS, Kollef MH, et al. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis 2012; 54:621.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Richter SS, Heilmann KP, Dohrn CL, et al. Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009. Antimicrob Agents Chemother 2011; 55:4154.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cosimi RA, Beik N, Kubiak DW, Johnson JA. Ceftaroline for Severe Methicillin-Resistant Staphylococcus aureus Infections: A Systematic Review. Open Forum Infect Dis 2017; 4:ofx084.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bassetti M, Russo A, Cilloniz C, et al. Ceftaroline for severe community-acquired pneumonia: A real-world two-centre experience in Italy and Spain. Int J Antimicrob Agents 2020; 55:105921.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 2010; 375:1557.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernández-Sabé N, Carratalà J, Dorca J, et al. Efficacy and safety of sequential amoxicillin-clavulanate in the treatment of anaerobic lung infections. Eur J Clin Microbiol Infect Dis 2003; 22:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           SCHWEPPE HI, KNOWLES JH, KANE L. Lung abscess. An analysis of the Massachusets General Hospital cases from 1943 through 1956. N Engl J Med 1961; 265:1039.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shafron RD, Tate CF Jr. Lung abscess: A five-year evaluation. Dis Chest 1968; 53:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pohlson EC, McNamara JJ, Char C, Kurata L. Lung abscess: a changing pattern of the disease. Am J Surg 1985; 150:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herth F, Ernst A, Becker HD. Endoscopic drainage of lung abscesses: technique and outcome. Chest 2005; 127:1378.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Unterman A, Fruchter O, Rosengarten D, et al. Bronchoscopic Drainage of Lung Abscesses Using a Pigtail Catheter. Respiration 2017; 93:99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wali SO. An update on the drainage of pyogenic lung abscesses. Ann Thorac Med 2012; 7:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wali SO, Shugaeri A, Samman YS, Abdelaziz M. Percutaneous drainage of pyogenic lung abscess. Scand J Infect Dis 2002; 34:673.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mueller PR, Berlin L. Complications of lung abscess aspiration and drainage. AJR Am J Roentgenol 2002; 178:1083.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Egyud M, Suzuki K. Post-resection complications: abscesses, empyemas, bronchopleural fistulas. J Thorac Dis 2018; 10:S3408.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vainrub B, Musher DM, Guinn GA, et al. Percutaneous drainage of lung abscess. Am Rev Respir Dis 1978; 117:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weissberg D. Percutaneous drainage of lung abscess. J Thorac Cardiovasc Surg 1984; 87:308.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mengoli L. Giant lung abscess treated by tube thoracostomy. J Thorac Cardiovasc Surg 1985; 90:186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schmitt GS, Ohar JM, Kanter KR, Naunheim KS. Indwelling transbronchial catheter drainage of pulmonary abscess. Ann Thorac Surg 1988; 45:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rowe LD, Keane WM, Jafek BW, Atkins JP Jr. Transbronchial drainage of pulmonary abscesses with the flexible fiberoptic bronchoscope. Laryngoscope 1979; 89:122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kelogrigoris M, Tsagouli P, Stathopoulos K, et al. CT-guided percutaneous drainage of lung abscesses: review of 40 cases. JBR-BTR 2011; 94:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duncan C, Nadolski GJ, Gade T, Hunt S. Understanding the Lung Abscess Microbiome: Outcomes of Percutaneous Lung Parenchymal Abscess Drainage with Microbiologic Correlation. Cardiovasc Intervent Radiol 2017; 40:902.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee JH, Hong H, Tamburrini M, Park CM. Percutaneous transthoracic catheter drainage for lung abscess: a systematic review and meta-analysis. Eur Radiol 2022; 32:1184.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitchell JD, Yu JA, Bishop A, et al. Thoracoscopic lobectomy and segmentectomy for infectious lung disease. Ann Thorac Surg 2012; 93:1033.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sun Y, Hou L, Xie H, et al. Wedge resection for localized infectious lesions: high margin/lesion ratio guaranteed operational safety. J Thorac Dis 2014; 6:1173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee CH, Liu YH, Lu MS, et al. Pneumonotomy: an alternative way for managing lung abscess. ANZ J Surg 2007; 77:852.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schweigert M, Dubecz A, Beron M, et al. Surgical therapy for necrotizing pneumonia and lung gangrene. Thorac Cardiovasc Surg 2013; 61:636.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yazbeck MF, Dahdel M, Kalra A, et al. Lung abscess: update on microbiology and management. Am J Ther 2014; 21:217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hirshberg B, Sklair-Levi M, Nir-Paz R, et al. Factors predicting mortality of patients with lung abscess. Chest 1999; 115:746.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 7030 Version 35.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26366400" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Lung abscess-etiology, diagnostic and treatment options.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2653801" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Aspiration pneumonia, necrotizing pneumonia, and lung abscess.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11095862" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Anaerobic Infections of the Lung.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31516903" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Postobstructive pneumonia in lung cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23857204" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : The microbiology of postobstructive pneumonia in lung cancer patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29392577" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Post-Obstructive Pneumonia in Patients with Cancer: A Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32099785" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Staphylococcal lung abscess in a child with cystic fibrosis: Case report&amp;review of literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3715782" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Lung abscess in cystic fibrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4595941" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Bacteriology and treatment of primary lung abscess.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Treatment of anaerobic pleuropulmonary infections
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Treatment of anaerobic pleuropulmonary infections
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4834618" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Anaerobic infections of the lung and pleural space.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7062576" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Clinical conferences at the Johns Hopkins Hospital: lung abscess.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5765630" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Clinical classification and analysis of 97 cases of lung abscess.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3556058" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Anaerobic bacterial infections of the lung.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15824979" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20389050" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Etiology and outcome of community-acquired lung abscess.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27548533" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : The Importance of Obligate Anaerobes and the Streptococcus anginosus Group in Pulmonary Abscess: A Clone Library Analysis Using Bronchoalveolar Lavage Fluid.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18231720" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14759242" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13541686" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Staphylococcal pneumonia; a review of 21 cases in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27512508" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : A 10-year retrospective review of pediatric lung abscesses from a single center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Pneumonia due to Bacillus friedlanderi
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30337980" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Clinical, Radiological and Bacteriological Profile of Lung Abscess - An Observational Hospital Based Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/788565" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Pulmonary infection in the compromised host: part I.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Significance of hemolytic streptococci bacteremia: Study of 246 patients
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5001752" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : The pseudomallei group: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10825069" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Melioidosis brain and lung abscess after travel to Sri Lanka.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3591819" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Legionella pneumophila lung abscess in a patient with systemic lupus erythematosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9986854" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Isolation of Legionella pneumophila by centrifugation of shell vial cell cultures from multiple liver and lung abscesses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6696329" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Cavitation in bacteremic pneumococcal pneumonia. Causal role of mixed infection with anaerobic bacteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17273583" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Lung abscess: analysis of 252 consecutive cases diagnosed between 1968 and 2004.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4095257" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Lung abscess and empyema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9372668" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Empyema thoracis and lung abscess caused by viridans streptococci.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6602513" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Differentiating lung abscess and empyema: radiography and computed tomography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/857717" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Diagnostic accuracy of transtracheal aspiration bacteriologic studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6635173" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Computed tomography of lung abscess and empyema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29984758" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : The Transbronchial Drainage of a Lung Abscess Using Endobronchial Ultrasonography with a Modified Guide Sheath.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33177229" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : To drain or not to drain? Abscess or empyema?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/688791" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Massive intrabronchial aspiration of contents of pulmonary abscess after fiberoptic bronchoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28633709" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Primary pulmonary actinomycosis: a retrospective analysis of 145 cases in mainland China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8634791" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : [Usefulness of transthoracic pulmonary aspiration biopsy in lung abscess secondary to neoplasm].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30808391" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Tricuspid valve infective endocarditis complicated with multiple lung abscesses and thoracic empyema as different pathogens: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22567485" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Complicated community-acquired Staphylococcus endocarditis and multiple lung abscesses: case report and review of literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19167651" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : MRSA tricuspid valve infective endocarditis with multiple embolic lung abscesses treated by combination therapy of vancomycin, rifampicin, and sulfamethoxazole/trimethoprim.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17015799" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Images in cardiovascular medicine. Rapid resolution of massive lung abscesses complicating tricuspid-valve endocarditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : The technique of transtracheal aspiration
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5067734" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Needle diagnosis of pneumonitis. Value in high-risk patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/498822" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Transtracheal aspiration. Guidelines for safety.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28992397" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Prognostic Significance of Cavitary Lung Nodules in Granulomatosis With Polyangiitis (Wegener's): A Clinical Imaging Study of 225 Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/644050" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : The air-fluid level in cavitary pulmonary tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2456183" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Chest roentgenogram in pulmonary tuberculosis. New data on an old test.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28449484" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Clinical presentation and characteristics of 25 adult cases of pulmonary sequestration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31451182" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : A Rare Case of Bronchopulmonary Sequestration Masquerading as Lung Abscess.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21311173" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Lung sequestration: a rare cause for pulmonary symptoms in adulthood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10471570" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : In vitro activity of gemifloxacin (SB 265805) against anaerobes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3914407" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Anaerobic infections. Part II.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6323094" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Susceptibility testing of anaerobic bacteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2221864" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16080108" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Moxifloxacin is efficacious for treatment of community-acquired lung abscesses in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6838068" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Clindamycin compared with penicillin for the treatment of anaerobic lung abscess.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1978771" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Clindamycin vs penicillin for anaerobic lung infections. High rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22247123" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21709080" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28702467" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Ceftaroline for Severe Methicillin-Resistant Staphylococcus aureus Infections: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32061999" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Ceftaroline for severe community-acquired pneumonia: A real-world two-centre experience in Italy and Spain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20206987" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Community-associated meticillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12649717" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Efficacy and safety of sequential amoxicillin-clavulanate in the treatment of anaerobic lung infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14039097" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Lung abscess. An analysis of the Massachusets General Hospital cases from 1943 through 1956.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Lung abscess: A five-year evaluation
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4014575" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Lung abscess: a changing pattern of the disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15821219" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Endoscopic drainage of lung abscesses: technique and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27951583" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Bronchoscopic Drainage of Lung Abscesses Using a Pigtail Catheter.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22347342" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : An update on the drainage of pyogenic lung abscesses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12374359" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Percutaneous drainage of pyogenic lung abscess.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11959705" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Complications of lung abscess aspiration and drainage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30505528" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Post-resection complications: abscesses, empyemas, bronchopleural fistulas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/413460" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Percutaneous drainage of lung abscess.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6694422" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Percutaneous drainage of lung abscess.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4021522" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Giant lung abscess treated by tube thoracostomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3337575" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Indwelling transbronchial catheter drainage of pulmonary abscess.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/423645" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Transbronchial drainage of pulmonary abscesses with the flexible fiberoptic bronchoscope.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21980735" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : CT-guided percutaneous drainage of lung abscesses: review of 40 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28321543" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Understanding the Lung Abscess Microbiome: Outcomes of Percutaneous Lung Parenchymal Abscess Drainage with Microbiologic Correlation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34327579" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Percutaneous transthoracic catheter drainage for lung abscess: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22386091" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Thoracoscopic lobectomy and segmentectomy for infectious lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25276357" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Wedge resection for localized infectious lesions: high margin/lesion ratio guaranteed operational safety.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17803547" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Pneumonotomy: an alternative way for managing lung abscess.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23034873" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Surgical therapy for necrotizing pneumonia and lung gangrene.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22248872" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Lung abscess: update on microbiology and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10084487" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Factors predicting mortality of patients with lung abscess.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
